CAR-T cell therapy for cancer: current challenges and future directions
2025 · Signal Transduction and Targeted Therapy · 115 citations
https://doi.org/10.1038/s41392-025-02269-w
T
Talía Velasco-Hernández
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.5K
Citations
19
h-index
27
i10-index
Talía Velasco-Hernández is an academic researcher from Instituto de Salud Carlos III. The author has contributed to research in topics: Acute Myeloid Leukemia Research & CAR-T cell therapy research & Hematopoietic Stem Cell Transplantation. The author has an h-index of 19, co-authored 51 publications.
ORCID: 0000-0003-2183-7443Papers by this author
worksA novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL
2021 · Molecular Therapy · 40 citations
https://doi.org/10.1016/j.ymthe.2021.08.033
Opportunities for CAR-T Cell Immunotherapy in HIV Cure
2023 · Viruses · 25 citations
https://doi.org/10.3390/v15030789
GPRC5C drives branched-chain amino acid metabolism in leukemogenesis
2023 · Blood Advances · 19 citations
https://doi.org/10.1182/bloodadvances.2023010460
Hif-1α Deletion May Lead to Adverse Treatment Effect in a Mouse Model of MLL-AF9-Driven AML
2018 · Stem Cell Reports · 15 citations
https://doi.org/10.1016/j.stemcr.2018.11.023
3138 – LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS
2025 · Experimental Hematology · 0 citations
https://doi.org/10.1016/j.exphem.2025.105079
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat